<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: methylphenidate</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Long-term ADHD treatment increases brain dopamine transporter levels, may affect drug efficacy</title>
   	 <description>Long-term treatment of attention deficit/hyperactivity disorder (ADHD) with certain stimulant medications may alter the density of the dopamine transporter, according to research published May 15 in the open access journal PLOS ONE by Gene-Jack Wang and colleagues from Brookhaven National Laboratory and the intramural program at NIH.</description>
     <link>http://medicalxpress.com/news/2013-05-long-term-adhd-treatment-brain-dopamine.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Wed, 15 May 2013 17:04:19 EST</pubDate>
	 <guid isPermaLink="false">news287856251</guid>
	 
</item>
<item>
     <title>Parent-focused classes may help tots at risk for ADHD</title>
   	 <description>(HealthDay)—Parent behavior training is an effective and well-studied intervention for preschoolers at risk of developing attention-deficit/hyperactivity disorder (ADHD), a new review shows.</description>
     <link>http://medicalxpress.com/news/2013-04-parent-focused-classes-tots-adhd.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Mon, 01 Apr 2013 11:30:01 EST</pubDate>
	 <guid isPermaLink="false">news284031544</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/parentfocuse.jpg" width="90" height="90" />
</item>
<item>
     <title>Is there a link between childhood obesity and ADHD, learning disabilities?</title>
   	 <description>A University of Illinois study has established a possible link between high-fat diets and such childhood brain-based conditions as attention deficit hyperactivity disorder (ADHD) and memory-dependent learning disabilities.</description>
     <link>http://medicalxpress.com/news/2013-02-link-childhood-obesity-adhd-disabilities.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Tue, 19 Feb 2013 12:30:01 EST</pubDate>
	 <guid isPermaLink="false">news280496481</guid>
	 
</item>
<item>
     <title>Physicians should not prescribe ADD drugs to healthy people</title>
   	 <description>Physicians in Canada should consider refusing to prescribe cognitive enhancement medications—also used to treat attention deficit disorder (ADD)—to healthy patients, states an analysis article in CMAJ (Canadian Medical Association Journal). Lack of evidence for benefits and possibility of harm, limited health care resources and professional integrity of physicians are reasons why this use is not acceptable.</description>
     <link>http://medicalxpress.com/news/2012-12-physicians-drugs-healthy-people.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 17 Dec 2012 12:00:05 EST</pubDate>
	 <guid isPermaLink="false">news274958998</guid>
	 
</item>
<item>
     <title>Treating cocaine dependence: A promising new pharmacotherapy</title>
   	 <description>Medication development efforts for cocaine dependence have yet to result in an FDA approved treatment. The powerful rewarding effects of cocaine, the profound disruptive impact of cocaine dependence on one's lifestyle, and the tendency of cocaine to attract people who make poor life choices and then exacerbate impulsive behavior all make cocaine a vexing clinical condition.</description>
     <link>http://medicalxpress.com/news/2012-11-cocaine-pharmacotherapy.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Wed, 28 Nov 2012 10:23:19 EST</pubDate>
	 <guid isPermaLink="false">news273320322</guid>
	 
</item>
<item>
     <title>Illegal drug users more likely to use new synthetic drugs and pharmaceuticals</title>
   	 <description>(Medical Xpress)—Methamphetamine users' use of synthetic cannabis products (such as Kronic) increased from ten per cent in 2010 to 41 per cent in 2011 an annual report on illegal drug use shows. Many of these synthetic cannabis products have subsequently been banned; they have contributed to an increase in new synthetic drug use, often in the form of 'legal highs', over the past three years.</description>
     <link>http://medicalxpress.com/news/2012-10-illegal-drug-users-synthetic-drugs.html</link>
	 <category>Addiction</category>
	 <pubDate>Thu, 18 Oct 2012 08:23:38 EST</pubDate>
	 <guid isPermaLink="false">news269767409</guid>
	 
</item>
<item>
     <title>Animal study: long-term ritalin doesn't impact growth</title>
   	 <description>(HealthDay) -- Chronic use of methylphenidate (Ritalin) in young monkeys has no significant effect on growth or the dopamine system, or the likelihood of becoming addicted to cocaine, according to a study published online July 18 in Neuropsychopharmacology.</description>
     <link>http://medicalxpress.com/news/2012-07-animal-long-term-ritalin-doesnt-impact.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Fri, 20 Jul 2012 13:30:02 EST</pubDate>
	 <guid isPermaLink="false">news262008331</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/animalstudyl.jpg" width="90" height="90" />
</item>
<item>
     <title>Long-term ADHD drug use appears safe, brain development not affected</title>
   	 <description>Drugs used to treat Attention Deficit Hyperactivity Disorder (ADHD) do not appear to have long-term effects on the brain, according to new animal research from Wake Forest Baptist Medical Center.</description>
     <link>http://medicalxpress.com/news/2012-07-long-term-adhd-drug-safe-brain.html</link>
	 <category>Autism spectrum disorders</category>
	 <pubDate>Wed, 18 Jul 2012 09:42:58 EST</pubDate>
	 <guid isPermaLink="false">news261823367</guid>
	 
</item>
<item>
     <title>Recovery from propofol anesthesia may be sped by use of common stimulant</title>
   	 <description>The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.</description>
     <link>http://medicalxpress.com/news/2012-04-recovery-propofol-anesthesia-sped-common.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 05 Apr 2012 14:55:57 EST</pubDate>
	 <guid isPermaLink="false">news252856538</guid>
	 
</item>
<item>
     <title>Study pinpoints effects of different doses of an ADHD drug, finds higher doses may harm learning</title>
   	 <description>New research with monkeys sheds light on how the drug methylphenidate may affect learning and memory in children with attention deficit hyperactivity disorder.</description>
     <link>http://medicalxpress.com/news/2012-03-effects-doses-adhd-drug-higher.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Thu, 08 Mar 2012 15:06:01 EST</pubDate>
	 <guid isPermaLink="false">news250441490</guid>
	 
</item>
<item>
     <title>Stimulant treatment for ADHD not associated with increased risk of cardiac events in youth</title>
   	 <description>Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.</description>
     <link>http://medicalxpress.com/news/2012-02-treatment-adhd-cardiac-events-youth.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Wed, 08 Feb 2012 10:44:33 EST</pubDate>
	 <guid isPermaLink="false">news247920251</guid>
	 
</item>
<item>
     <title>Mechanism of calming hyperactivity by psychostimulant drugs identified</title>
   	 <description>It has long been known that psychostimulant drugs have the paradoxical effect of reducing hyperactivity. [Psychostimulant drugs include methylphenidate &amp;#150; known by the trade names Ritalin, Concerta, and Methylin &amp;#150; and methamphetamine]. Since the mid-1950s, millions of children and adults have been prescribed stimulant medications to control attention deficit hyperactivity disorder (ADHD). But for more than seven decades, since the first experiment that gave an amphetamine drug to children diagnosed with behavioral problems, scientists have not known how stimulants work to control hyperactivity.</description>
     <link>http://medicalxpress.com/news/2012-02-mechanism-calming-hyperactivity-psychostimulant-drugs.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Tue, 07 Feb 2012 17:20:00 EST</pubDate>
	 <guid isPermaLink="false">news247857590</guid>
	 
</item>
<item>
     <title>Children with certain dopamine system gene variants respond better to ADHD drug</title>
   	 <description>Children with certain dopamine system gene variants have an improved response to methylphenidate - the most commonly prescribed medication for Attention Deficit Hyperactivity Disorder - in a finding that could help eliminate the guesswork from prescribing effective medications for children with ADHD.</description>
     <link>http://medicalxpress.com/news/2011-10-children-dopamine-gene-variants-adhd.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Fri, 21 Oct 2011 10:17:34 EST</pubDate>
	 <guid isPermaLink="false">news238411045</guid>
	 
</item>
<item>
     <title>Prescribed stimulant use for ADHD continues to rise steadily</title>
   	 <description>The prescribed use of stimulant medications to treat attention deficit hyperactivity disorder (ADHD) rose slowly but steadily from 1996 to 2008, according to a study conducted by the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ). The study was published online ahead of print September 28, 2011, in the American Journal of Psychiatry.</description>
     <link>http://medicalxpress.com/news/2011-09-adhd-steadily.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Wed, 28 Sep 2011 03:34:51 EST</pubDate>
	 <guid isPermaLink="false">news236399666</guid>
	 
</item>
<item>
     <title>Common stimulant may speed recovery from general anesthesia</title>
   	 <description>Administration of the commonly used stimulant drug methylphenidate (Ritalin) was able to speed recovery from general anesthesia in an animal study conducted at Massachusetts General Hospital (MGH). The report, appearing in the October issue of Anesthesiology, is the first demonstration in mammals of what could be a safe and effective way to induce arousal from general anesthesia. While there are drugs to counteract many of the agents used by anesthesiologists &amp;#150; such as pain killers and muscle relaxants &amp;#150; until now there has been no way to actively reverse the unconsciousness induced by general anesthesia.</description>
     <link>http://medicalxpress.com/news/2011-09-common-recovery-anesthesia.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 21 Sep 2011 08:48:28 EST</pubDate>
	 <guid isPermaLink="false">news235813689</guid>
	 
</item>
<item>
     <title>Study suggests ADHD drugs may affect male puberty</title>
   	 <description>(Medical Xpress) -- A new study released this week in the Proceedings of the National Academy of Science reveals that the medication methylphenidate, best known as Ritalin, may delay puberty in males. The researchers caution that this study was performed in monkeys and more research needs to be done before it can determine possible effects on humans.</description>
     <link>http://medicalxpress.com/news/2011-09-adhd-drugs-affect-male-puberty.html</link>
	 <category>Attention deficit disorders</category>
	 <pubDate>Tue, 20 Sep 2011 10:34:03 EST</pubDate>
	 <guid isPermaLink="false">news235733605</guid>
	 
</item>
<item>
     <title>Time to address stimulant abuse on our campuses</title>
   	 <description>Universities and colleges need to do more to protect young adults from the dangers of illicit stimulant use and to educate them about harms, argue the authors of an editorial in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://medicalxpress.com/news/2011-09-abuse-campuses.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 06 Sep 2011 12:34:25 EST</pubDate>
	 <guid isPermaLink="false">news234531232</guid>
	 
</item>


</channel>
</rss>
